To investigate whether LOXL2-enriched sEV-treated fibroblasts affect tumor cell adhesion, we treated MRC5 cells with sEVs derived from normoxic Cal-27 cells, sEVs derived from hypoxic Cal-27 cells with or without LOXL2 KD. Here, LOXL2 is linked to neoplasm.